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Abstract
BACKGROUND: Depression is one of the most common chronic psychological disorders around the world 
presenting with many interpersonal and social problems. Common antidepressants have various adverse effects 
and are not safe for long-term therapy. Alternative safer remedies are under investigation with a focus on herbal 
therapies. Hydrastis canadensis is a perennial herb, rich in many phytoconstituents ranging from amino acids to 
alkaloids, flavonoids, and steroids. It is also widely used in Chinese folklore tradition for mood elevating effects; 
however, this has not been scientifically proven. 
AIM: This study is thus aimed at evaluating antidepressant potential of this plant.
MATERIALS AND METHODS: Ethanolic extract of dried root of plant was prepared by maceration technique and was 
subjected to phytochemical screening. Mice were divided into four groups (n = 5). Tween 80, 2 ml (negative control), 
fluoxetine 10 mg/kg (positive control), and extracts at 150 mg/kg and 250 mg/kg were administered by intraperitoneal 
route to mice in their respective groups. The locomotor activity was assessed for 5 min using actimeter at 0, 30, and 
60 min for each animal. Increase in locomotion was an index of antidepressant effect. The mean value of each group 
was calculated and results were compared by one-way ANOVA. p < 0.05 was considered statistically significant.
RESULTS: Phytochemical screening yielded positive results for alkaloids and saponins. Locomotion was increased 
in groups treated with fluoxetine and extract at 150 mg and 250 mg/kg dose when compared to negative control (1% 
– Tween 80). This was an index of antidepressant effect. However, the results were statistically significant (p < 0.05) 
for fluoxetine and extract treated groups at 250 mg/kg. Fluoxetine demonstrated the highest antidepressant effect.
CONCLUSION: This study has demonstrated the antidepressant potential of Hydrastis canadensis ethanolic extract. 
Further studies are required to validate these findings on other experimental models. The specific active constituent 
and effects at cellular level need to be evaluated.
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Introduction
Depression is one of the most common 
chronic psychological disorders presenting around the 
world [1]. Depression presents with many interpersonal 
and social problems. Some of the signs and symptoms 
are changes in sleep pattern, negative thoughts, and 
loss of interest in daily activities [2]. This disorder 
leads to functional impairment and in chronic cases 
can cause cardiovascular complications such as 
myocardial infarction and stroke. The most important 
complication due to this disease is suicide. The main 
cause of depression is mainly due to low levels of 
neurotransmitters in the central nervous system such 
as dopamine and serotonin [2]. Endocrinological 
factors along with abnormality of circadian rhythm 
are some of the other reasons for this disorder [3]. 
Treatment for depression includes many prescription 
drugs. The main group of drugs includes TCAs (tricyclic 
antidepressants), SSRIs (selective serotonin reuptake 
inhibitors), and NARIs (non-adrenaline reuptake 
inhibitors). Patient compliance is low as adverse 
effects are common and are basis of discontinuation 
of treatment [4]. SSRIs are used more commonly, but 
are associated with side effects such as drowsiness, 
diarrhea, insomnia, restlessness, and sexual 
problems [5]. Tricyclic antidepressants are generally 
not tolerated well and are associated with many 
more adverse effects, mostly anticholinergic effects 
(blurred vision, dry mouth, constipation, and urinary 
retention) [6]. NARIs and SNRIs have similar effects 
with addition of sweating and flushing, tachycardia, and 
hypertension [7]. Along with adverse effects, the newer 
drugs also carry financial burden. Therefore, there 
is a need of discovering newer, safer, cost-effective 
alternative therapies. Golden seal is also called 
Hydrastis canadensis belongs to the buttercup family. It 
is a perennial herb with a yellowish color. This herb was 
approved in the USA Pharmacopoeia and in the national 
formulary in the 18th and 19th century [8]. Conventionally, 
it is used for treatment and prevention of flu and cold. 
It is a rich herb with many phytoconstituents ranging 
from amino acids to alkaloids, flavonoids, and steroids. 
The most common constituents found in this herb are 
alkaloids including hydrastine, canadine, and berberine 
[9]. An alkaloid, berberine, derived from this plant is 
used in Chinese folklore tradition for mood elevating 
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effects [10], [11]. This herb is useful for treating and 
preventing flu and cold. It has documented antibacterial, 
immune enhancing, anti-inflammatory, antioxidant, and 
anticancer effects [12], [13], [14], [15]. This plant is rich 
in phytoconstituents; however, its effects at central 
nervous system have not been evaluated. As the plant 
is used as an antidepressant in alternative medicine 
and is rich in various implicated phytoconstituents, it 
can demonstrate CNS stimulant effects. Therefore, our 
study is aimed at evaluating the antidepressant effects 
in mice by assessing the locomotor index using an 
actimeter.
Materials and Methods
Drugs and plant materials
Fluoxetine hydrochloride 10 mg tablets 
(Prozac (TN), SPIMACO, Al-Qassim Pharmaceuticals 
Goldenseal (Hydrastis canadensis) root) and GNC 
Herbs (Starwest Botanicals) were used.
Preparation of ethanolic extract
Ethanolic extract was prepared by maceration 
technique. A 50 g of dried root (Hydrastis canadensis) 
was crushed to fine powder and placed in 500 ml 
ethanol [16]. The mixture will be shaken frequently 
for 3 days [16]. Next, after filtration, the filtrate was 
dried in rotary evaporator (temperature at 60°C, 
rotations at 80/min). The dried filtrate was stored in 
clean sealed test tubes and kept in refrigerator until 
further use.
Phytochemical analysis
Extract was evaluated for the presence of 
flavonoids, phenols, alkaloids, steroids, and tannins by 
preliminary phytochemical screening [17].
Animals/Grouping
Swiss albino mice (18–30 g) of either sex were 
provided by the animal house at King Khalid University, 
Abha, Saudi Arabia. Animals were kept in free area in 
cage, maintained on standard light cycle (12 h light/
dark), and supplied with standard food and water. All 
experiments were carried out after ethical approval from 
Ethics Committee, King Khalid University. The animals 
were grouped as follows (n = 5):
•	 Group I: Tween-80 (negative control)
•	 Group II: Fluoxetine 10 mg/kg (positive control)
•	 Group III: H. canadensis extract 150 mg/kg
•	 Group IV: H. canadensis extract 250 mg/kg
Antidepressant activity (Locomotor activity)
The animal locomotor behavior was monitored 
using actimeter (Panlab Harvard Apparatus). This 
apparatus has a square arena with a light source 
provided with photocells. The locomotor activity was 
recorded with a digital counter. Each animal was 
placed individually in the apparatus and its basal 
movement was recorded for 5 min [18]. Next, each 
animal was treated with respective drug (intraperitoneal 
injection) and activity score was recorded after 30 
min and 1 h [18]. The extract dose was 150 mg/
kg and 250 mg/kg [19], [20]. Extract was dissolved 
in 1% Tween-80 for intraperitoneal injection. Mean 
of activity score for each group was calculated and 
compared. Increased activity score was taken as index 
of antidepression [18].
Statistical analysis
All data were expressed as mean ± SEM 
and analyzed using ANOVA. p < 0.05 was considered 
statistically significant.
Results
The phytochemical analysis yielded positive 
results for alkaloids and saponins. Flavonoids, steroids, and 
tannins were negative (Table 1). Mean of each group was 
taken and compared. Locomotion was increased in groups 
treated with fluoxetine and extract at 150 mg and 250 mg/
kg dose at 30 min and 60 min when compared to negative 
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Figure 1: Assessment of locomotor activity
control (Figure 1). This was an index of antidepressant 
effect. However, the results were statistically significant 
(p < 0.05) for fluoxetine (at 30 min and 60 min) and extract 
treated groups at 250 mg/kg (at 60 min). Fluoxetine 
demonstrated the highest antidepressant effect followed 
on by extract at 250 mg/kg dose (Table 2).
Table 1: Phytochemical screening of Hydrastis canadensis 
extract
Compound Tannins Alkaloids Flavonoids Steroids Saponins
Result Negative Positive Negative Negative Positive
 Batooletal.H.Canadensis;AntidepressantEffects
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Table 2: Mean ± SEM (locomotor activity in 5 min)
Group 0 min  
(baseline)
30 min  
(after dose)
60 min  
(after dose)
Group I – Tween 1 ml
Negative control
702 ± 8.9 699 ± 10.9 698 ± 10.4
Group II – Fluoxetine 10 mg/kg 698 ± 8.5 742 ± 15.5* 774 ± 15.7*
Group III – H. Canadensis extract
150 mg/kg
696 ± 5.9 712 ± 11.7 710 ± 17.2
Group IV – H. Canadensis extract 
250 mg/kg
703 ± 8.5 718 ± 2.3 746 ± 14.0*
*P value is significant (<0.05) when compared to negative control (calculated by one-way ANOVA)
Discussion
Depression is a debilitating disease with many 
effects at personal and social levels. Although there 
are many drugs available for its treatment, they come 
with the burden of adverse effects and dependence. 
Traditional plants are used nowadays to counteract 
this disease. One famous plant is St. Johns Wort, it has 
extensive application as an antidepressant [21]. New 
plants are being evaluated for the same. The active 
constituents in plants, which have proven effects as 
antidepressants, are flavonoids and alkaloids. In this 
study, phytochemical analysis of plant was positive 
for alkaloids and saponins. The extract documented 
statistically significant antidepressant potential at 
250 mg/kg. Alkaloids have documented antidepressant 
effects. One famous alkaloid, berberine, derived 
from plants is already in use as a mood stimulant in 
China [22]. Some of its effects include modulation 
of serotonergic, noradrenergic, and dopaminergic 
pathways [22]. Berberine has also shown significant 
effects on immobility time and climbing behavior in 
neuropsychopharmacology experiments carried out in 
rodents [23]. An alkaloid derived from researchers in 
Brazil from Psychotria myriantha Mull., also exhibited 
antidepressant-like effect when studied on serotonin 
system in rat hippocampus [24]. This alkaloid has 
numerous effects, such as anti-inflammatory, antitumor, 
hypolipidemic, antioxidant, and antibacterial [10]. Its 
effects at neurological levels are an emerging topic. 
This alkaloid has also been reported to have good 
penetration and dissolvability in brain [25].
The most important effects of these plant 
alkaloids are due to their effects on monoamine 
oxidase (MAO A and B). These enzymes are critical 
for the metabolism of various neurotransmitters in 
the brain such as norepinephrine, serotonin, and 
dopamine [26], [27]. Inhibition on MAOs could increase 
monoamine neurotransmitters in brain and reduce 
depressive symptoms [28].
According to monoamine hypothesis, the 
main pathology in depression is dysregulation of 
neurotransmitters, mainly serotonin, dopamine, and 
norepinephrine [29]. Alkaloids have shown to regulate 
these biogenic neurotransmitters in animal studies. 
These neurotransmitters are released from neurons 
during electrical synaptic transmission in the central 
nervous system.
Monoamine oxidase inhibitors are group 
of drugs that are already available in the market for 
treating depression. These drugs, however, come 
with adverse effects, drug interactions, and increased 
noncompliance. Some of the side effects are sedation, 
euphoria, and postural hypotension [30]. Animal 
studies have proven that plant-based alkaloids have 
antidepressant potential. These are vastly available 
in nature and could be a more economical, safer, and 
long-term therapy for depression.
Conclusion
This study has indicated antidepressant 
potential of the ethanolic extract of Hydrastis canadensis 
root. This could provide an alternative, safer, and cost-
effective therapy for the treatment of depressive illness.
Limitation
This is a preliminary study. Larger scale 
studies with increased number of animals and different 
test models will be required for validation of results. The 
mechanism at cellular level could not be evaluated due 
to limitation in facility resources.
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